| Model Number |
DTMB1QQ |
| Medical Device Problem Codes |
Device Alarm System (1012); Failure to Interrogate (1332); Pacing Problem (1439)
|
| Health Effect - Clinical Codes |
Heart Failure/Congestive Heart Failure (4446); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/02/2025
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was further reported that the clinician was waiting to perform a device change-out as the patient was being assess for left ventricular assist device (lvad) implant.However, it was noted that patient later passed away due to heart failure before they could receive a replacement or lvad.
|
| |
|
Event or Problem Description
|
|
It was reported that the cardiac resynchronization therapy defibrillator (crt-d) was unable to be interrogated, and surface electrocardiogram and monitors did not show any indication of pacing.It was also reported that the mobile programmer application was unable to identify the crt-d.It was noted that the patient was not enrolled in the remote monitoring network website.When a magnet was applied, there was no magnet response tone.The physician believed the crt-d battery was just depleted.It was noted that no product performance issues led to the battery depletion.No further actions were taken to date.The crt-d remains in use.No patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Product event summary: the device was returned and analyzed.Analysis of the returned device was inconclusive.Analysis of the hybrid revealed the device was returned in a no telemetry and no output condition.The device was fully functional and operated under normal current drain when powered with an external supply.The device passed all manual therapy delivery testing.There was no evidence of a high current drain condition, and no hybrid anomalies were observed.Analysis of the battery revealed no internal defects or abnormalities were found that would cause premature battery depletion.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|